- CA$16.99m
- CA$15.98m
- CA$7.55m
- 37
- 71
- 40
- 48
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.5 | 9.61 | 4.41 | 7.19 | 7.55 |
Cost of Revenue | |||||
Gross Profit | 6.87 | 5.84 | 1.22 | 4.11 | 4.45 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.9 | 11.5 | -0.309 | 7.52 | 6.88 |
Operating Profit | -1.4 | -1.84 | 4.72 | -0.329 | 0.671 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.48 | -2.9 | 3.93 | -0.374 | 0.703 |
Net Income After Taxes | -2.48 | -2.9 | 3.93 | -0.374 | 0.703 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.48 | -2.9 | 3.93 | -0.374 | 0.703 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.48 | -2.9 | 3.93 | -0.374 | 0.703 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.022 | -1.87 | -0.224 | 0.001 |